Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:26 PM
Study NCT ID:
NCT03570658
Status:
COMPLETED
Last Update Posted:
2020-02-28
First Post:
2018-06-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-18
First Submit QC Date:
None
Study First Post Date:
2018-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-01-23
Results First Submit QC Date:
None
Results First Post Date:
2020-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-17
Last Update Post Date:
2020-02-28
Last Update Post Date Type:
ACTUAL